The Economic Times · 21 Oct, 10:09 · Healthcare briefing

Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in India

Sanofi has secured approval from the Central Drugs Standard Control Organisation for its Qftilia therapy, targeting haemophilia patients in India.

What it means for you ↓ Courses for this story

31%salary uplift reported after healthcare management certification

13%projected growth in health services roles this decade

2.1xmore interview callbacks with a verified credential

20days to your first credential

The briefing

The story
in brief.

What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.

Sanofi has secured approval from the Central Drugs Standard Control Organisation for its Qftilia therapy, targeting haemophilia patients in India. This regulatory milestone allows patients to manage bleeding episodes more effectively. This development marks a significant expansion of advanced treatment options within the Indian healthcare market, reflecting growing investment in specialised pharmaceutical care. For industry observers, it signals continued regulatory alignment and market access for innovative therapies, potentially influencing future healthcare delivery models and patient outcomes across the region.

Employer demand for Medical Physics skills — indexed growth since 2019
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)

Your move

What this means
for your career.

Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.

This approval signals a robust demand for specialised pharmaceutical expertise in India. If you work in healthcare, focus on regulatory compliance and clinical data analysis to stay relevant. Professionals in supply chain management should monitor cold-chain logistics requirements for new biologics. For those in marketing, understanding patient-centric narratives in rare diseases is crucial. Smart professionals will now upskill in healthcare management and regulatory affairs to navigate this evolving landscape. Consider exploring courses in compliance to ensure your organisation meets stringent CDSCO standards. This shift favours those who can bridge clinical innovation with operational efficiency, so prioritise skills that enhance cross-functional collaboration in regulated environments.

For this story, the fields that convert it into pay are Medical Physics, Python Data Visualisation Libraries Mastery, API Development and Staff Recruitment And Retention — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.

Indicative salary uplift in the fields matched to this story
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below

Matched to this story

Enrol in these
to benefit.

These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.